Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00204529
Status:
COMPLETED
Last Update Posted:
2017-05-03
First Post:
2005-09-12
Brief Title:
Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB
Sponsor:
University Hospital Tuebingen
Organization:
University Hospital Tuebingen
Organization Data
Organization:
University Hospital Tuebingen
Class:
OTHER
Study ID:
ML17840
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Tuebingen
Lead Sponsor Class:
OTHER
Responsible Party:
Thomas Eigentler
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Hospital Tuebingen
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dermatologic Cooperative Oncology Group | OTHER |